Literature DB >> 9841983

Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen.

M Fein1, J H Peters, P Chandrasoma, A P Ireland, S Oberg, M P Ritter, C G Bremner, J A Hagen, T R DeMeester.   

Abstract

In the rat model, esophageal adenocarcinoma reproducibly develops following surgically induced duodenal reflux into the esophagus and administration of nitrosamine. In addition, decreasing gastric acid via partial or total gastrectomy increases the prevalence of adenocarcinoma in this model. We questioned whether carcinogen was necessary for cancer development in the gastrectomized model and whether esophageal acidification could reverse the effect of gastrectomy. Three groups of 26 rats each were randomized to a surgical procedure to produce one of the following reflux models: gastroduodenal reflux by esophagojejunostomy, duodenal reflux by total gastrectomy and esophagojejunostomy, or no reflux by Roux-en-Y reconstruction. In a second experiment, 42 rats were operated on to induce duodenal reflux. One week following surgery, they were randomized to receive acidified water (pH 1.8) or tap water. The animals were killed at 24 weeks of age, and the esophagus was evaluated histologically. All animals with reflux had severe esophagitis and 87% developed columnar lining of the distal esophagus. Nearly half (48%) developed adenocarcinoma at the anastomotic site 16 weeks postoperatively and without carcinogen administration. Cancer prevalence did not differ between animals with gastroduodenal or duodenal reflux but tended to be lower in animals receiving acidified water. Duodenoesophageal reflux is carcinogenic in the rat model. Exogenous carcinogen is not necessary for cancer development in gastrectomized rats.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9841983     DOI: 10.1016/s1091-255x(98)80021-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.267


  26 in total

1.  Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats.

Authors:  S E Attwood; T C Smyrk; T R DeMeester; S S Mirvish; H J Stein; R A Hinder
Journal:  Surgery       Date:  1992-05       Impact factor: 3.982

2.  Ambulatory oesophageal bile reflux monitoring in Barrett's oesophagus.

Authors:  M T Caldwell; P Lawlor; P J Byrne; T N Walsh; T P Hennessy
Journal:  Br J Surg       Date:  1995-05       Impact factor: 6.939

3.  Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats.

Authors:  K Miwa; H Sahara; M Segawa; S Kinami; T Sato; I Miyazaki; T Hattori
Journal:  Int J Cancer       Date:  1996-07-17       Impact factor: 7.396

4.  Barrett's esophagus: development of dysplasia and adenocarcinoma.

Authors:  W Hameeteman; G N Tytgat; H J Houthoff; J G van den Tweel
Journal:  Gastroenterology       Date:  1989-05       Impact factor: 22.682

5.  Gastric juice protects against the development of esophageal adenocarcinoma in the rat.

Authors:  A P Ireland; J H Peters; T C Smyrk; T R DeMeester; G W Clark; S S Mirvish; T E Adrian
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

6.  The role of colon anaerobes in the metabolism of bile acids and steroids, and its relation to colon cancer.

Authors:  M J Hill
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

7.  Does duodenal juice reflux into the esophagus of patients with complicated GERD? Evaluation of a fiberoptic sensor for bilirubin.

Authors:  W K Kauer; P Burdiles; A P Ireland; G W Clark; J H Peters; C G Bremner; T R DeMeester
Journal:  Am J Surg       Date:  1995-01       Impact factor: 2.565

8.  Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus.

Authors:  G Champion; J E Richter; M F Vaezi; S Singh; R Alexander
Journal:  Gastroenterology       Date:  1994-09       Impact factor: 22.682

9.  Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus.

Authors:  M F Vaezi; J E Richter
Journal:  Surgery       Date:  1995-06       Impact factor: 3.982

10.  Induction of oesophageal and forestomach carcinomas in rats by reflux of duodenal contents.

Authors:  K Miwa; M Segawa; Y Takano; H Matsumoto; H Sahara; M Yagi; I Miyazaki; T Hattori
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

View more
  51 in total

1.  Combination of endoscopic argon plasma coagulation and antireflux surgery for treatment of Barrett's esophagus.

Authors:  H Tigges; K H Fuchs; J Maroske; M Fein; S M Freys; J Müller; A Thiede
Journal:  J Gastrointest Surg       Date:  2001 May-Jun       Impact factor: 3.452

2.  Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells.

Authors:  Xiaofang Huo; Stefanie Juergens; Xi Zhang; Davood Rezaei; Chunhua Yu; Eric D Strauch; Jian-Ying Wang; Edaire Cheng; Frank Meyer; David H Wang; Qiuyang Zhang; Stuart J Spechler; Rhonda F Souza
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-02       Impact factor: 4.052

3.  Impact of the biliary diversion procedure on carcinogenesis in Barrett's esophagus surgically induced by duodenoesophageal reflux in rats.

Authors:  Koji Nishijima; Koichi Miwa; Tomoharu Miyashita; Shinichi Kinami; Itasu Ninomiya; Sachio Fushida; Takashi Fujimura; Takanori Hattori
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

4.  Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia.

Authors:  Michael Quante; Govind Bhagat; Julian A Abrams; Frederic Marache; Pamela Good; Michele D Lee; Yoomi Lee; Richard Friedman; Samuel Asfaha; Zinaida Dubeykovskaya; Umar Mahmood; Jose-Luiz Figueiredo; Jan Kitajewski; Carrie Shawber; Charles J Lightdale; Anil K Rustgi; Timothy C Wang
Journal:  Cancer Cell       Date:  2012-01-17       Impact factor: 31.743

5.  Morbidity and mortality results from a prospective randomized controlled trial comparing Billroth I and Roux-en-Y reconstructive procedures after distal gastrectomy for gastric cancer.

Authors:  Hiroshi Imamura; Shuji Takiguchi; Kazuyoshi Yamamoto; Motohiro Hirao; Junya Fujita; Isao Miyashiro; Yukinori Kurokawa; Yoshiyuki Fujiwara; Masaki Mori; Yuichiro Doki
Journal:  World J Surg       Date:  2012-03       Impact factor: 3.352

6.  A comparison of postoperative quality of life and dysfunction after Billroth I and Roux-en-Y reconstruction following distal gastrectomy for gastric cancer: results from a multi-institutional RCT.

Authors:  Shuji Takiguchi; Kazuyoshi Yamamoto; Motohiro Hirao; Hiroshi Imamura; Junya Fujita; Masahiko Yano; Kenji Kobayashi; Yutaka Kimura; Yukinori Kurokawa; Masaki Mori; Yuichiro Doki
Journal:  Gastric Cancer       Date:  2011-10-13       Impact factor: 7.370

7.  Barrett's esophagus and animal models.

Authors:  Ryan A Macke; Katie S Nason; Ken-ichi Mukaisho; Takanori Hattori; Takashi Fujimura; Shozo Sasaki; Katsunobu Oyama; Tomoharu Miyashita; Tetsuo Ohta; Koichi Miwa; Michael K Gibson; Ali Zaidi; Usha Malhotra; Ajlan Atasoy; Tyler Foxwell; Blair Jobe
Journal:  Ann N Y Acad Sci       Date:  2011-09       Impact factor: 5.691

8.  Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Katerina Dvorak; George S Watts; Lois Ramsey; Hana Holubec; Claire M Payne; Carol Bernstein; Gareth J Jenkins; Richard E Sampliner; Anil Prasad; Harinder S Garewal; Harris Bernstein
Journal:  Am J Gastroenterol       Date:  2009-01-27       Impact factor: 10.864

Review 9.  Barrett esophagus: what a mouse model can teach us about human disease.

Authors:  Michael Quante; Julian A Abrams; Yoomi Lee; Timothy C Wang
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

10.  Induction of MUC5AC mucin by conjugated bile acids in the esophagus involves the phosphatidylinositol 3-kinase/protein kinase C/activator protein-1 pathway.

Authors:  Shumei Song; James C Byrd; Sushovan Guha; Kai-Feng Liu; Dimpy Koul; Robert S Bresalier
Journal:  Cancer       Date:  2010-12-14       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.